Variant report
Variant | esv3444223 |
---|---|
Chromosome Location | chr7:66303317-66305265 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559322990 | chr7:66303454-66303455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs539367979 | chr7:66303490-66303491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572817074 | chr7:66303530-66303531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545123265 | chr7:66303630-66303631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150710449 | chr7:66303665-66303666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530771515 | chr7:66303668-66303669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs184893418 | chr7:66303681-66303682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4717323 | chr7:66303740-66303741 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs143674012 | chr7:66303772-66303773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs549077487 | chr7:66303780-66303781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566103094 | chr7:66303788-66303789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528558111 | chr7:66303819-66303820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551900039 | chr7:66303820-66303821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs571500343 | chr7:66303826-66303827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537208817 | chr7:66303876-66303877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs9638237 | chr7:66303885-66303886 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567590871 | chr7:66303894-66303895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140644041 | chr7:66303940-66303941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555478207 | chr7:66303973-66303974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs369104967 | chr7:66303998-66303999 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144530457 | chr7:66303999-66304000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs190135869 | chr7:66304001-66304002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs544772166 | chr7:66304013-66304014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs558657849 | chr7:66304014-66304015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs575418991 | chr7:66304015-66304016 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544373261 | chr7:66304021-66304022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs35987451 | chr7:66304022-66304023 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
28 | rs181657208 | chr7:66304023-66304024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs74439166 | chr7:66304027-66304028 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs551625909 | chr7:66304032-66304033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs78322474 | chr7:66304035-66304036 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200230740 | chr7:66304036-66304037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs377399679 | chr7:66304040-66304041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs201403071 | chr7:66304041-66304042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540551339 | chr7:66304042-66304043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370994004 | chr7:66304043-66304044 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs373933144 | chr7:66304050-66304051 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs200988483 | chr7:66304051-66304052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs201893566 | chr7:66304053-66304054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559486720 | chr7:66304060-66304061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563858471 | chr7:66304062-66304063 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs528528983 | chr7:66304070-66304071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375466952 | chr7:66304079-66304080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs113729544 | chr7:66304090-66304091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs186309937 | chr7:66304091-66304092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191058671 | chr7:66304101-66304102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs200162616 | chr7:66304117-66304118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs182064084 | chr7:66304119-66304120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs371155746 | chr7:66304124-66304125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs200435058 | chr7:66304132-66304133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Biliary cancer | 19435499 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Cancer | 21183584 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 24379144 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lissencephaly | 21572526 | CNVD |
Breast cancer | 17603634 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Astrocytoma | 22246337 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Bladder cancer | 21909424 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Cancer | 20164920 | CNVD |
Prostate cancer | 18632612 | CNVD |
Schizophrenia | 21346763 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 22522925 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 21911935 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:66297600-66309000 | Weak transcription | Right Atrium | heart |
2 | chr7:66304400-66305800 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
3 | chr7:66304600-66304800 | Enhancers | HepG2 | liver |
4 | chr7:66304800-66305000 | Enhancers | Primary T cells fromperipheralblood | blood |
5 | chr7:66304800-66305000 | Flanking Active TSS | HepG2 | liver |
6 | chr7:66305000-66305600 | Enhancers | HepG2 | liver |